Financials
Financial year 2025
MPL PHARMA from Ciney, company number BE0885177557, closed financial year 2025 with a result of € 113,425 after tax. For that financial year MPL PHARMA recorded a gross margin of € 340,284 and equity of € 724,196. Compared with financial year 2024, the result moved from € 101,120 to € 113,425. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 31, 2025.
€ 724,196
▼ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 113,425
▲ 12% vs 2024
Profit after tax over the fiscal year.
€ 232,594
▼ 50% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 204,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 84,443
▼ 3% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 25,331
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 131,598
▼ 26% vs 2024
€ 46,067 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 98,293
Supplier invoices still open on the last day of the fiscal year.
€ 36,151
▲ 4% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 289,439 | € 332,645 | € 332,485 | € 340,284 | ▲ 2% |
| Profit after taxes | € 93,928 | € 111,146 | € 101,120 | € 113,425 | ▲ 12% |
| Equity | € 659,505 | € 757,651 | € 814,771 | € 724,196 | ▼ 11% |
| Total debts | € 535,739 | € 482,583 | € 464,377 | € 459,534 | ▼ 1% |
| Cash | € 380,090 | € 468,064 | € 465,291 | € 232,594 | ▼ 50% |
| Land & buildings | € 428,396 | € 443,399 | € 482,959 | € 498,832 | ▲ 3% |
| Retained profit | € 459,505 | € 557,651 | € 594,771 | € 504,196 | ▼ 15% |
| Dividend | € 0 | € 13,000 | € 44,000 | € 204,000 | ▲ € 160,000 |
| Bank debt | € 283,529 | € 222,505 | € 177,257 | € 131,598 | ▼ 26% |
| Balance sheet total | € 1,195,244 | € 1,240,233 | € 1,279,148 | € 1,183,729 | ▼ 7% |
| Employees (FTE) | 1.8 | 1.6 | - | - |
Key figures of MPL PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to MPL PHARMA?
What happened at MPL PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 113,425 (▲ 12% vs 2024). Source: NBB ↗
- New establishment in Ciney. KBO
- Start of the company according to the CBE. KBO
In short
From € 93,928 profit in 2022 to € 113,425 profit in 2025.
Paid € 204,554 in corporate taxes since 2022.
Best year ever: 2025, with € 113,425 profit.
On average € 207,900 of value added per employee in 2023.
A new publication or filing at MPL PHARMA? We notify you, reason included.
Follow MPL PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind MPL PHARMA is MARIE-PIERRE LAURENT.
Directors
According to the 2025 annual accounts
MARIE-PIERRE LAURENT
Director
Establishments
Establishment units
Physical locations of this company
Rue du Saint-Amour(Haversin) 1
5590 Ciney
Rue des Ecoles(Haversin) 118
5590 Ciney
Active since 1 January 2007
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0885.177.557
- VAT number
- BE 0885.177.557
- Registered office
- Rue du Saint-Amour(Haversin) 1, 5590 Ciney
- Names & denominations
- MPL PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 November 2006
- Peppol
- Active · Active since 3 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers